The contraceptive vaginal ring: female adolescents' knowledge, attitudes and plans for use

Contraception

Volumn 76, Issue 6, 2007, Pages 444-450

  Carey, Alexandra S ^a,b   Chiappetta, Laurel ^a,b   Tremont, Katie ^a,b   Murray, Pamela J ^a,b   Gold, Melanie A ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

Adolescent; Attitude; Contraceptive; Contraceptive vaginal ring; Future plans; Knowledge; Pregnancy prevention; Sexually active

Indexed keywords

ADOLESCENT; ADULT; ANALYTIC METHOD; ARTICLE; ATTITUDE; CONTRACEPTION; CONTROLLED STUDY; FEMALE; HUMAN; INTERVIEW; KNOWLEDGE; LOGISTIC REGRESSION ANALYSIS; NORMAL HUMAN; REPRODUCTIVE HEALTH; SEXUAL BEHAVIOR; TAMPON; VAGINA RING;

ADOLESCENT; ADULT; AMBULATORY CARE FACILITIES; CONTRACEPTION BEHAVIOR; CONTRACEPTIVE DEVICES, FEMALE; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INTERVIEWS AS TOPIC;

EID: 36549048996     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2007.07.013     Document Type: Article

References (22)

1. Guttmacher Institute. U.S. teenage pregnancy statistics: national and state trends and trends by race and ethnicity. http://www.guttmacher.org/pubs/2006/09/11/USTPstats.pdf Accessed Sept. 12, 2006
2. Darroch J.E., Frost J.J., and Singh S. Teenage sexual and reproductive behaviour in developed countries: can more progress be made? Occasional report (2001), Alan Guttmacher Institute (AGI), New York 1-122 No. 3
3. Finer L.B., and Henshaw S.K. Disparities in rates of unintended pregnancy in the United States, 1994 and 2001. Perspect Sex Reprod Health 38 (2006) 90-96
4. Abma J.C., Martinez G.M., and Mosher W.D. Teenagers in the United States: sexual activity, contraceptive use, and childbearing 2002. National Center for Health Statistics. Vital Health Stat 23 24 (2004)
5. Santelli J.S., Morrow B., Anderson J.E., and Lindberg L.D. Contraceptive use and pregnancy risk among US high school students, 1991-2003. Perspect Sex Reprod Health 38 (2006) 106-111
6. Organon International. NuvaRing® (etonogestrel/ethinyl estradiol). http://www.organon.com/products/gynecology/contraception/nuvaring/asp Accessed April 25, 2007
7. Mulders T.M., Dieben T.O., and Bennink H.J. Ovarian function with a novel combined contraceptive vaginal ring. Hum Reprod 17 (2002) 2594-2599
8. Mulders T.M., and Dieben T.O. Use of the novel combined contraceptive vaginal ring NuvaRing for ovulation inhibition. Fertil Steril 75 (2001) 865-870
9. Dieben T.O., Roumen F.J., and Apter D. Efficacy, cycle control, and user acceptability of a novel combined contraceptive vaginal ring. Obstet Gynecol 100 (2002) 585-593
10. Szarewski A. High acceptability and satisfaction with NuvaRing use. Eur J Contracept Reprod Health Care 7 (2002) 31-36
11. Novak A., de la Loge C., Abetz L., and van der Meulen E.A. The combined contraceptive vaginal ring, NuvaRing: an international study of user acceptability. Contraception 67 (2003) 187-194
12. Roumen F.J., op ten Berg M.M., and Hoomans E.H. The combined contraceptive vaginal ring (NuvaRing): first experience in daily clinical practice in the Netherlands. Eur J Contracept Reprod Health Care 11 (2006) 14-22
13. Waldbaum A.S., Funk S., and Alexander N.J. Acceptability of NuvaRing, a new method of combined contraception. Fertil Steril 78 (2002) 25-35
14. Roumen F.J., Apter D., Mulders T.M., and Dieben T.O. Efficacy, tolerability and acceptability of a novel contraceptive vaginal ring releasing etonogestrel and ethinyl oestradiol. Hum Reprod 16 (2001) 469-475
15. Westhoff C., Osborne L.M., Schafer J.E., and Morroni C. Bleeding patterns after immediate initiation of an oral compared with a vaginal hormonal contraceptive. Obstet Gynecol 106 (2005) 89-96
16. Bjarnadottir R.I., Tuppurainen M., and Killick S.R. Comparison of cycle control with a combined contraceptive vaginal ring and oral levonorgestrel/ethinyl estradiol. Am J Obstet Gynecol 186 (2002) 389-395
17. van den Heuvel M.W., van Bragt A.J., Alnabawy A.K., and Kaptein M.C. Comparison of ethinylestradiol pharmacokinetics in three hormonal contraceptive formulations: the vaginal ring, the transdermal patch, and an oral contraceptive. Contraception 72 (2005) 168-174
18. Timmer C.J., and Mulders T.M. Pharmacokinetics of etonogestrel and ethinylestradiol released from a combined contraceptive vaginal ring. Clin Pharm 39 (2000) 233-242
19. Veres S., Miller L., and Burington B. A comparison between the vaginal ring and oral contraceptives. Obstet Gynecol 104 (2004) 555-563
20. Smith S.M., Baskin G.B., and Marx P.A. Estrogen protects against vaginal transmission of simian immunodeficiency virus. J Infect Dis 182 (2000) 708-715
21. Eschenbach D.A., Davick P.R., Williams B.L., et al. Prevalence of hydrogen peroxide-producing Lactobacillus species in normal women and women with bacterial vaginosis. J Clin Microbiol 27 (1989) 251-256
22. Schafer J.E., Osborne L.M., Davis A.R., and Westhoff C. Acceptability and satisfaction using Quick Start with the contraceptive vaginal ring versus an oral contraceptive. Contraception 73 (2006) 488-492